BAMS
AGIO icon

Bellevue Asset Management (Switzerland)’s Agios Pharmaceuticals AGIO Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$3.51M Hold
54,000
– – 0.53% 61
2015
Q3 		$3.81M Buy
54,000
+13,000
+32% +$1.27M 0.62% 53
2015
Q2 		$4.56M Sell
41,000
-17,000
-29% -$1.83M 0.63% 55
2015
Q1 		$5.47M Buy
+58,000
New +$6.5M 0.76% 47

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s AGIO Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) held its Agios Pharmaceuticals (AGIO) position steady in Q4 2015 at 54,000 shares worth $3.51M. The position accounts for 0.53% of the portfolio, ranked #61.

Bellevue Asset Management (Switzerland) first reported a position in AGIO in Q1 2015 and has held it in 4 quarters since. The position peaked at $5.47M in Q1 2015. 145 funds tracked by Wall St. Rank hold AGIO as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 54,000 shares of Agios Pharmaceuticals worth $3.51M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) left its Agios Pharmaceuticals share count unchanged in Q4 2015.
  • Agios Pharmaceuticals made up 0.53% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #61 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Agios Pharmaceuticals in Q1 2015 and has held it in 4 quarters since.
  • Bellevue Asset Management (Switzerland)'s Agios Pharmaceuticals position peaked at $5.47M in Q1 2015.
  • 145 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.